Skip to content
March 29, 2024

Equity.Guru

Investment information for the new generation

Search

asthma

Even during my university days, I would find myself grasping my chest, wheezing after a short 15-minute walk to campus. In terms of fitness, I would consider myself to…
In this episode, we revisit Valeo Pharma (VPH.C) to get an update on their product portfolio, stock price, and financials. Is VPH.C a good long term investment? Tune In!…
Valeo Pharma (VPH.C) is a specialty pharmaceutical company, engages in the acquisition, in-licensing, and commercialization of pharmaceutical products with a primary focus on neurodegenerative diseases, oncology and supportive care, and…
Valeo Pharma (VPH.C) announced today that it has completed implementation of its new corporate structure and launched full commercial activities in support of Enerzair Breezhaler triple therapy and Atectura…
Valeo Pharma (VPH.C) announced that they have begun commercialization of their Enerzair Breezhaler and Atectura Breezhaler following the shipment of the product across Canada and the deployment of their…
Valeo Pharma (VPH.C) has announced a non-brokered private placement of up to 4,000 unsecured non-convertible debentures units a a price of $1000 per unit for maximum gross proceeds of…
It’s been a hell of a month for Vapen MJ Ventures (VAPN.C), which just pulled in its first patent and is up $0.30 since mid-month. And why not? Vapen…